Chloe Cole Act

HR 5483, the Chloe Cole Act, prohibits health care professionals, hospitals, or clinics from providing certain gender-affirming treatments to minors under 18 that aim to alter their body to align with a gender identity different from their sex assigned at birth. This includes puberty blockers, sex hormones, and specific surgeries, unless the treatment falls under narrow exceptions like medically necessary care for disorders of sexual development, injuries, or detransition. The bill creates a private right for affected minors or their guardians to sue providers for damages in federal court, with strict liability for violations. It applies when interstate commerce is involved (e.g., payments, travel, communications) and sets a 25-year statute of limitations from the minor’s 18th birthday.